Evommune, Inc. (EVMN)
$5.88-2.81%Close
SELLCRISIS · day 25
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $83M
- Beta
- 0.96
- P/E (TTM)
- -2.08
- Short % float
- 20.95%
- Days to cover
- 3.9
- SI change
- +0.6%
- 1W
- -11.04%
- 1M
- -43.62%
- vs SPY 1W
- -10.91%
- vs SPY 1M
- -46.13%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on EVMN?
- LOPJLB’s latest quantitative signal on Evommune, Inc. (EVMN) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is EVMN in?
- Evommune, Inc. (EVMN) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Evommune, Inc. (EVMN) do?
- Evommune, Inc. is a United States-based clinical-stage biotechnology company dedicated to advancing novel therapeutic solutions. Their primary focus lies in addressing the underlying mechanisms of chronic inflammatory diseases. Initial clinical development efforts are concentrated on conditions such as chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. The company's inves…